ReviewJCO precision oncology2023

Adjuvant Therapy for Renal Cell Carcinoma: End Points, Outcomes, and Risk Assessments.

Joseph J Boyle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.